Comparison of Bare Metal Stents Versus Drug-Eluting Stents on Clinical Decision Making in Patients With Previous Percutaneous Coronary Intervention Admitted for Suspected Acute Coronary Syndrome

American Journal of Cardiology

Volumn 98, Issue 3, 2006, Pages 338-340

  Joshi, Jatin ^a   Menon, Venu ^b   Vaidean, Georgeta ^c   Mohan, Siva ^a   Thomas, Jerome ^a   Kelly, Robert V ^a   Stouffer, George A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DECISION MAKING; DRUG ELUTING STENT; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; RETROSPECTIVE STUDY; REVASCULARIZATION; TIME SERIES ANALYSIS; TREATMENT INDICATION;

ACUTE DISEASE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DECISION MAKING; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METALS; MIDDLE AGED; RETROSPECTIVE STUDIES; SIROLIMUS; STENTS; SYNDROME; TREATMENT OUTCOME;

EID: 33745940758     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.02.038     Document Type: Article

References (6)

1. Kastrati A., Dibra A., Eberle S., Mehilli J., Suarez D.L., Goy J.J., Ulm K., and Schomig A. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease. meta-analysis of randomized trials. JAMA 294 (2005) 819-825
2. Babapulle M.N., Joseph L., Belisle P., Brophy J.M., and Eisenberg M.J. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 364 (2004) 583-591
3. Kandzari D.E., Roe M.T., Ohman E.M., Milford-Beland S., Chen A.Y., Lytle B.L., Cohen D.J., Smith S.C., Harrington R.A., Gibler W.B., and Peterson E.D. Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes. Am J Cardiol 96 (2005) 750-755
4. Zahn R., Hamm C.W., Schneider S., Zeymer U., Nienaber C.A., Richardt G., Kelm M., Levenson B., Bonzel T., Tebbe U., Sabin G., and Senges J. Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry). Am J Cardiol 95 (2005) 1302-1308
5. Glaser R., Selzer F., Faxon D.P., Laskey W.K., Cohen H.A., Slater J., Detre K.M., and Wilensky R.L. Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation 111 (2005) 143-149
6. Cutlip D.E., Chhabra A.G., Baim D.S., Chauhan M.S., Marulkar S., Massaro J., Bakhai A., Cohen D.J., Kuntz R.E., and Ho K.K. Beyond restenosis. five-year clinical outcomes from second-generation coronary stent trials. Circulation 110 (2004) 1226-1230